Patients using Remicade (infliximab) for rheumatoid arthritis or Crohn's now...watched for heart failure

Patients using Remicade (infliximab) for rheumatoid arthritis or Crohn's now need to be watched for heart failure.

This is because of a higher incidence of mortality and worsening heart failure when Remicade is given to patients with moderate to severe heart failure.

This is a surprise.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote